Universal Computer Interface System
Vacumetrics
FDA Clearance Information
The universal computer interface system was cleared by the FDA via the 510(k) pathway on May 3, 1985. It is manufactured by Vacumetrics and classified as a Class 2 device under product code BZM.
What It Is
FDA-Cleared Indications
- Noninvasive human-computer interaction
- Use in neuromotor applications
Clinical Applications
- Providing a noninvasive interface for controlling or interacting with a computer
- Supporting computer interaction in neuromotor applications
- Providing an alternative to conventional computer input devices when those methods are impractical
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The available FDA record does not provide detailed specifications for device dimensions, interfaces, compatibility, or operating environment.
- The available record does not identify MRI labeling or establish that the system is MR Safe, MR Conditional, or MR Unsafe; MRI use should not be assumed without manufacturer documentation.
- The device is noninvasive, but users may still require assessment of neuromotor function, positioning, and ability to operate the interface reliably.
- Contraindications, cleaning instructions, maintenance requirements, and expected service life should be confirmed in the original labeling.
- The 1985 clearance does not by itself confirm compatibility with current computers, operating systems, or clinical information systems.
Frequently Asked Questions
What are the clinical indications for universal computer interface system?
The device is indicated for use in neuromotor applications, facilitating human-computer interaction without traditional input devices.
What outcomes have been reported in clinical studies?
Studies have reported improved user interaction efficiency and intuitiveness in neuromotor applications.
What complications have been reported?
Safety data indicate potential vulnerabilities to adversarial attacks on neural network components, but no direct physical adverse events have been reported.